Clinical Trials Browser

Phase 1 × Neuroendocrine Tumors × tislelizumab × Clear all

NCT05167071 2025-04-27

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

Phase 1 Active not recruiting

Neuroendocrine Tumors